MEDFIN is filed with the CBE under the catch-all “Agenten en makelaars in bankdiensten”, a code that says little about what the company actually does. Private Limited, started on 10 February 2022, 1 establishment.

What is the address of MEDFIN?

The registered office of MEDFIN is located at Rue Albert 1er 78A, 4280 Hannut.

Is MEDFIN still active?

Yes. According to the CBE (31 October 2026) MEDFIN is active, legal situation “Normale toestand”, started on 10 February 2022.

Is MEDFIN registered on Peppol?

No, MEDFIN is currently not registered on the Peppol network.

What is the enterprise number of MEDFIN?

The enterprise number of MEDFIN is BE0781817129.

When was MEDFIN founded?

MEDFIN was founded on 10 February 2022.

Who are the directors of MEDFIN?

According to the 2025 annual accounts, the directors of MEDFIN are: INFINIA SRL, Catherine Doyen SRL.

Is MEDFIN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 February 2022; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDFIN make in 2025?

MEDFIN posted a profit after taxes of € 17,660 in financial year 2025.

What is the revenue of MEDFIN?

As a small company, MEDFIN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 267,307.

How much does an employee at MEDFIN earn?

The average wage cost per full-time employee at MEDFIN was € 58,800 in 2024: staff costs of € 270,288 for 4.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

MEDFIN (Private Limited) - Hannut - BE0781817129

Dossier MEDFIN, printed on 31 October 2026 from databakkes.be/en/0781817129/medfin. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

MEDFIN from Hannut, company number BE0781817129, closed financial year 2025 with a result of € 17,660 after tax. For that financial year MEDFIN recorded a gross margin of € 267,307 and equity of € 25,786. Compared with financial year 2024, the result moved from € 24,755 to € 17,660. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 14, 2026.

What it is worth Growing

€ 25,786

▲ 217% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 17,660

▼ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 13,222

▲ 234% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 23,286.

People and assets in 2025

Wage cost

€ 186,977

▼ 31% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,785

▼ 38% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 159,126

▲ 7% vs 2024

€ 34,320 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 5,894

▲ 67% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 22,775

▼ 24% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -4,993 Gross margin 2022: € -4,993 First fiscal year in the series	€ 410,081 Gross margin 2023: € 410,081 ▲ € 415,074 vs 2022 (€ -4,993) Favourable step	€ 428,479 Gross margin 2024: € 428,479 ▲ 4% vs 2023 (€ 410,081) Favourable step	€ 267,307 Gross margin 2025: € 267,307 ▼ 38% vs 2024 (€ 428,479) Unfavourable step	▼ 38%
Profit after taxes	€ -6,990 Profit after taxes 2022: € -6,990 First fiscal year in the series	€ -12,140 Profit after taxes 2023: € -12,140 ▼ € 5,150 vs 2022 (€ -6,990) Unfavourable step	€ 24,755 Profit after taxes 2024: € 24,755 ▲ € 36,895 vs 2023 (€ -12,140) Favourable step	€ 17,660 Profit after taxes 2025: € 17,660 ▼ 29% vs 2024 (€ 24,755) Unfavourable step	▼ 29%
Equity	€ -4,490 Equity 2022: € -4,490 First fiscal year in the series	€ -16,630 Equity 2023: € -16,630 ▼ € 12,140 vs 2022 (€ -4,490) Unfavourable step	€ 8,125 Equity 2024: € 8,125 ▲ € 24,755 vs 2023 (€ -16,630) Favourable step	€ 25,786 Equity 2025: € 25,786 ▲ 217% vs 2024 (€ 8,125) Favourable step	▲ 217%
Total debts	€ 12,816 Total debts 2022: € 12,816 First fiscal year in the series	€ 493,816 Total debts 2023: € 493,816 ▲ € 480,999 vs 2022 (€ 12,816) Unfavourable step	€ 288,489 Total debts 2024: € 288,489 ▼ 42% vs 2023 (€ 493,816) Favourable step	€ 225,839 Total debts 2025: € 225,839 ▼ 22% vs 2024 (€ 288,489) Favourable step	▼ 22%
Cash	€ 2,229 Cash 2022: € 2,229 First fiscal year in the series	€ 2,312 Cash 2023: € 2,312 ▲ 4% vs 2022 (€ 2,229) Favourable step	€ 3,953 Cash 2024: € 3,953 ▲ 71% vs 2023 (€ 2,312) Favourable step	€ 13,222 Cash 2025: € 13,222 ▲ 234% vs 2024 (€ 3,953) Favourable step	▲ 234%
Retained profit	€ -6,990 Retained profit 2022: € -6,990 First fiscal year in the series	€ -19,130 Retained profit 2023: € -19,130 ▼ € 12,140 vs 2022 (€ -6,990) Unfavourable step	€ 5,625 Retained profit 2024: € 5,625 ▲ € 24,755 vs 2023 (€ -19,130) Favourable step	€ 23,286 Retained profit 2025: € 23,286 ▲ € 17,660 vs 2024 (€ 5,625) Favourable step	▲ € 17,660
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 347,265 Bank debt 2023: € 347,265 Unchanged (€ 0) Unfavourable step	€ 148,838 Bank debt 2024: € 148,838 ▼ 57% vs 2023 (€ 347,265) Favourable step	€ 159,126 Bank debt 2025: € 159,126 ▲ 7% vs 2024 (€ 148,838) Unfavourable step	▲ 7%
Balance sheet total	€ 8,327 Balance sheet total 2022: € 8,327 First fiscal year in the series	€ 477,186 Balance sheet total 2023: € 477,186 ▲ € 468,860 vs 2022 (€ 8,327) Unchanged	€ 296,614 Balance sheet total 2024: € 296,614 ▼ 38% vs 2023 (€ 477,186) Unchanged	€ 251,624 Balance sheet total 2025: € 251,624 ▼ 15% vs 2024 (€ 296,614) Unchanged	▼ 15%
Employees (FTE)	-	5.2 Employees (FTE) 2023: 5.2 First fiscal year in the series	4.6 Employees (FTE) 2024: 4.6 ▼ 0.6 vs 2023 (5.2) Unchanged	-

Key figures of MEDFIN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDFIN?

What happened at MEDFIN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 14, 2026 New annual accounts for financial year 2025: profit of € 17,660 (▼ 29% vs 2024). filed late Source: NBB ↗
2023 INFINIA SRL became a director. NBB
2023 Catherine Doyen SRL became a director. NBB
Feb 10, 2022 New establishment in Hannut. KBO
Feb 10, 2022 Start of the company according to the CBE. KBO

In short

From € 6,990 loss in 2022 to € 17,660 profit in 2025.

Paid € 17,181 in corporate taxes since 2022.

Best year ever: 2024, with € 24,755 profit.

On average € 93,100 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

Catherine DOYEN 100%

MEDICAL FINANCE 25%

The stake of Catherine DOYEN, MEDICAL FINANCE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

MEDFIN

Behind MEDFIN are INFINIA SRL and Catherine Doyen SRL. The shares are held by Catherine DOYEN (100%) and MEDICAL FINANCE (25%).

Directors

According to the 2025 annual accounts

INFINIA SRL

Director · represented by DEISSER Nicolas

Also active at: INFINIA GROUP

since 2023

Catherine Doyen SRL

Director · represented by DOYEN Catherine

Also active at: INFINIA GROUP

since 2023

Shareholders

Catherine DOYEN

100%

MEDICAL FINANCE

25%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Albert 1er 78A

4280 Hannut

2.328.823.312

Rue Albert 1er 78 box A

4280 Hannut

Active since 10 February 2022

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

INFINIA GROUP same network

€ 982,539 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0781.817.129
VAT number: BE 0781.817.129
Registered office: Rue Albert 1er 78A, 4280 Hannut
Names & denominations: MEDFIN
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 February 2022
Peppol: Not registered
Activities · NACE: Agenten en makelaars in bankdiensten

View on CBE Public ↗ Annual accounts (NBB) ↗